Macrolide Drugs Market 2021: Global Industry Analysis Report to 2027
The global macrolide drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Macrolides are a class of antibiotics that includes erythromycin, roxithromycin, azithromycin and clarithromycin and are used in the treatment of respiratory, skin, soft tissue, sexually transmitted, H. pylori and atypical mycobacterial infections. The major factor for the growth of the market during the forecast period is the growing demand for antibiotics.
Additionally, the market is also
growing owing to the rising prevalence of bacterial skin infections along with
supportive government policies and legislation. Moreover, North America held
the largest share in the market in 2020 owing to the well-developed healthcare
infrastructure, increased R&D activities by the pharmaceutical companies as
well as rapid adoption of new along with better healthcare technologies.
To Request a Sample of our Report on Macrolide Drugs
Market: https://www.omrglobal.com/request-sample/macrolide-drugs-market
Some major players in the market include GlaxoSmithKline
plc, Novartis AG, and Pfizer Inc., among others. The market players are
contributing significantly to the growth of the market by the adoption of
various strategies including mergers & acquisitions, geographical
expansion, partnerships and collaborations, and new product launches, to stay
competitive in the market. For instance, in March 2018, Macrolide Pharmaceuticals
announced that it received a CARB-X award of up to $6.8M to support the
development of a novel fully synthetic, orally available macrolide antibiotic
with Gram-negative activity, to treat serious infections including
drug-resistant complicated urinary tract infections (cUTI).
Market Coverage
•
The market number available for – 2020-2027
•
Base year- 2020
•
Forecast period- 2021-2027
• Segment
Covered-
·
By Drugs
·
By Route of Administration
·
By Infection
·
By End-User
• Regions
Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
•
Competitive Landscape- GlaxoSmithKline
plc, Novartis AG, and Pfizer Inc., among others.
(Get 15% Discount on Buying this Report)
A
full Report of Macrolide Drugs Market is Available at: https://www.omrglobal.com/industry-reports/macrolide-drugs-market
Global Macrolide Drugs Market Report by Segment
By Drugs
• Azithromycin
• Clarithromycin
• Erythromycin
• Fidaxomicin
• Telithromycin
By Route of Administration
• Oral
• Parenteral
By Infection
• Mycoplasma
Pneumoniae
• Legionella
SP
• Bordetella
Pertussis
• Symptomatic
Cat-Scratch Disease
• Bacillary
angiomatosis
• Peliosishepatis
• Cerebral
Toxoplasmosis
• Uncomplicated
Skin Infections
By End-User
• Hospital
• Dermatology
Clinic
• Ambulatory
Center
• Research
Laboratories
Global Macrolide Drugs Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment